Tick-Borne Diseases – Talk Bio

Actionable Insights Powered by AI

Pfizer and Valneva Announce Positive Phase 2 Results for Lyme Disease Vaccine Candidate VLA15

8 months ago talkbio0Tagged development aspects, Lyme Disease, Pfizer, Tick-Borne Diseases, Vaccines, Valneva, VLA15

Lyme disease, VLA15, Pfizer, Valneva, vaccine development, tick-borne diseases